Treatment of Hypertension in Mild Asthmatic Patients With Atenolol

Krauss, Shimon; Spitz, Edward; Krauss, Agota; Grizotzki, Bronja; Clement, Sinai
December 1984
Angiology;Dec1984, Vol. 35 Issue 12, p773
Academic Journal
Fourteen patients with uncomplicated essential hypertension and mild asthma were treated with Atenolol 50-125 mg/day for up to 8 months. Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), rate pressure index (RPI), stress testing time (STT) and peak expiratory flow rate (PEFR) were measured before, during and after stress testing (ST) before and during treatment. Atenolol significantly lowered HR, SBP, DBP and RPI. It prolonged STT and had no effect on PEFR. Furthermore, Atenolol did not worsen the patient's asthma except for one patient. The drug did not interfere with the bronchodilatation effect of salbutamol. Atenolol can be used cautiously to treat hypertension in asthmatic patients under certain conditions.


Related Articles

  • 'Prescribe antihypertensives for all over a certain age'.  // Pulse;5/20/2009, Vol. 69 Issue 17, p3 

    The article reports on the prescription of antihypertensives in all patients with cardiovascular (CV) disease in Great Britain. Research suggests that antihypertensives should be prescribed to these patients regardless of their pre-treatment blood pressure. It was found out that the percentage...

  • Antihypertensive use across Europe varies widely.  // PharmacoEconomics & Outcomes News;2/10/2007, Issue 521, p9 

    The article discusses research being done on the use of antihypertensive agents across European countries. It references a study by P. Stolk et al, published in the December 2006 issue of the "Journal of Human Hypertension." The study assesses the variation in the utilization of antihypertensive...

  • Effect of Antihypertensive Therapy on Serum Lipids in Newly Diagnosed Essential Hypertensive Men. Nandeesha, Hanumanthappa; Pavithran, Purushothaman; Madanmohan, T. // Angiology;Apr/May2009, Vol. 60 Issue 2, p217 

    The effect of antihypertensives on serum lipids in newly diagnosed male essential hypertensive patients was studied. The participants (n = 99) were randomly allocated to receive amlodipine, atenolol, enalapril, hydrochlorothiazide, and a combination of amlodipine and atenolol. Lipid parameters...

  • Technology for the Production and Utilization of Food Protein-Derived Anti-hypertensive Peptides: A Review. Aluko, Rotimi E. // Recent Patents on Biotechnology;Nov2007, Vol. 1 Issue 3, p260 

    Angiotensin converting enzyme (ACE)-inhibitory drugs have been used as therapeutic tools in the clinical management of hypertension and associated cardiovascular disorders. Food-derived ACE-inhibitory peptides have lower potency than similar acting drugs but the peptides usually have no adverse...

  • The Management of Hypertension in the Overweight and Obese Patient: Is Weight Reduction Sufficient? Jacob, Stephan // Drugs;2004, Vol. 64 Issue 11, p1263 

    This article comments on a review appearing in the July 2004 issue of "Drugs" regarding the management of hypertension in the overweight and obese patient using the drug Orlistat. The review focused on the use of dietary and lifestyle modification, anti-obesity and hypertensive drug therapeutic...

  • The Authors’ Reply. Douketis, James D.; Sharma, Arya M. // Drugs;2004, Vol. 64 Issue 11, p1264 

    This article is a reply to a commentary appearing in the July 2004 issue of "Drugs" regarding the management of hypertension in the overweight and obese patient. According to the commentary, the drug Orlistat produces inconsistent effect on blood pressure and may benefit only patients who have...

  • Pharmacokinetics of the Effect of Nebivolol 5mg on Airway Patency in Patients with Mild to Moderate Bronchial Asthma and Arterial Hypertension: A Randomised, Placebo-Controlled Study. Dal Negro, R.W.; Tognella, S.; Micheletto, C. // Clinical Drug Investigation;2002, Vol. 22 Issue 3, p197 

    Objective: To evaluate the pharmacokinetics of a single dose of nebivolol 5mg on airway conductance in patients with stable asthma and arterial hypertension. Design: Randomised, double-blind, placebo-controlled, crossover study. Patients: Twelve nonsmokers (five males; mean age 55.2 ± 11.7...

  • SECTION 2: CARDIOVASCULAR SYSTEM.  // Physician Assistants' Prescribing Reference;Fall2010, Vol. 17 Issue 3, p3 

    The article lists several drugs for cardiovascular system which include the antihypertensive Accupril from Pfizer, antianginal Cardizem LA from Biovail, and antiarrhythmic Mavic from Abbott.

  • CHOOSE MAXIMAL STATIN MONOTHERAPY BEFORE UNPROVEN COMBINATION. Harkness, James R.; Blumenthal, Roger S. // Cardiology Today;Feb2012 Practical Lipidology, p15 

    The article focuses on clinical studies comparing the effectiveness of high-dose statin monotherapy and combination statin therapy in reducing cardiovascular disease risk.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics